Correction to 'Refractory Alopecia Areata of the Beard: Novel Improvement Through Exosome Therapy With Signs of Hair Repigmentation'
December 2025
in “
Clinical Case Reports
”
TLDR The exosome injections were from stem cells and plants, not umbilical cords.
The document is a correction to a previously published case report on refractory alopecia areata of the beard, which initially described the treatment as using exosome injections derived from human umbilical cord. The correction clarifies that the exosome injections actually consisted of human adipose-derived mesenchymal stem cell exosomes (ASCE+ HRLV) and plant-derived exosomes (DERMAFIRM Rx Elysee Exosome Ampoule Skin Booster). These corrections pertain only to the classification and description of the exosome products and do not affect the clinical outcomes or conclusions of the original report. The authors request an official correction to reflect these changes.